Hosted by the College of Chemical and Life Sciences, UM Office of Technology Commercialization, and Mtech VentureAccelerator.

Download PDF Flyer for the Event

WHAT:
Suzanne Sensabaugh presentation on the FDA process, followed by one-on-one consultations
WHEN:
Thursday, May 15th, 10-10:30 a.m. (presentation), 10:30-Noon: One-on-one consultations for University of Maryland faculty, researchers, and staff (by appointment--contact Jim Chung at jwchung@umd.edu to reserve your consultation)
WHERE:
Room 3101 of the Biosciences Research Building

This is a rare and free opportunity for you to learn what it will take to get the necessary FDA approvals for your invention to make it into the real world. As part of the monthly Entrepreneur Office Hours at the College of Chemical and Life Sciences, special guest Suzanne Sensabaugh, VP of Biopharmaceutical Development at MDS Pharma Services and an expert on FDA regulations, will explain the FDA approval process for life sciences related inventions on Thursday, May 15, from 10-10:30 a.m. in room 3101 of the Biosciences Research Building. Afterward (10:30am-12 noon), she will be answering your specific questions about how to navigate the FDA process in one-on-one consultations by appointment.

As always, Gayatri Varma, Director of the Office of Technology Commercialization and Jim Chung, Director of the VentureAccelerator, will also be available during the office hours to answer your questions on technology transfer and entrepreneurship. Please contact Jim Chung at jwchung@umd.edu to reserve your personal consultation with Suzanne Sensabaugh.

-------------------------------------------------
SUZANNE M. SENSABAUGH BIOGRAPHY
------------------------------------------------

Suzanne M. Sensabaugh, an alumna of the College of Chemical and Life Sciences, is VP of Biopharmaceutical Development for MDS Pharma Services, where she is responsible for managing and directing the consulting group in development and regulatory services and providing professional guidance to clients. Prior to this position, she was VP, Regulatory Affairs, and Senior Director for Global Biogenerics, Teva Pharmaceutical Industries Ltd. She has more than 10 years of experience at the FDA/CBER as a researcher, product reviewer and inspector for biologics. She was also involved in the development and implementation of SOPs, guidance, regulations and laws. Suzanne serves on company boards, is the industry representative to numerous scientific committees and the ICH, and teaches Clinical Development at Johns Hopkins University. She received her MBA from Duke University, an MS.c. in Biotechnology from Johns Hopkins University and a BS.c. in Zoology from the University of Maryland.